Hormonal Therapy
43 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.
Hormonal Therapy (43)
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Degarelix |
GnRH Antagonist | Solid Tumour (Prostate) | ||
|
Molecule
Degarelix
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
GnRH Antagonist |
||||
Deslorelin |
LHRH Agonist | Solid Tumour (Prostate/Breast) | ||
|
Molecule
Deslorelin
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate/Breast)
Drug Class / Mechanism
LHRH Agonist |
||||
Diethylstilbestrol |
Progestin / Estrogen / Antiandrogen | Solid Tumour (Breast/Prostate/Endometrial) | ||
|
Molecule
Diethylstilbestrol
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
||||
Elacestrant |
Selective Estrogen Receptor Degrader (SERD) | Solid Tumour (Breast) | ||
|
Molecule
Elacestrant
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Degrader (SERD) |
||||
Ethinyl Estradiol (Oncology Use) |
Progestin / Estrogen / Antiandrogen | Solid Tumour (Breast/Prostate/Endometrial) | ||
|
Molecule
Ethinyl Estradiol (Oncology Use)
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
||||
Exemestane |
Aromatase Inhibitor | Solid Tumour (Breast) | ||
|
Molecule
Exemestane
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Aromatase Inhibitor |
||||
Fadrozole |
Aromatase Inhibitor | Solid Tumour (Breast) | ||
|
Molecule
Fadrozole
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Aromatase Inhibitor |
||||
Flutamide |
Antiandrogen | Solid Tumour (Prostate) | ||
|
Molecule
Flutamide
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
Antiandrogen |
||||
Formestane |
Aromatase Inhibitor | Solid Tumour (Breast) | ||
|
Molecule
Formestane
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Aromatase Inhibitor |
||||
Fosfestrol |
Progestin / Estrogen / Antiandrogen | Solid Tumour (Breast/Prostate/Endometrial) | ||
|
Molecule
Fosfestrol
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
||||
Fulvestrant |
Selective Estrogen Receptor Degrader (SERD) | Solid Tumour (Breast) | ||
|
Molecule
Fulvestrant
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Degrader (SERD) |
||||
Galeterone |
CYP17 / Androgen Synthesis Inhibitor | Solid Tumour (Prostate) | ||
|
Molecule
Galeterone
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
CYP17 / Androgen Synthesis Inhibitor |
||||
DegarelixHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
GnRH Antagonist |
|
DeslorelinHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate/Breast)
Drug Class / Mechanism
LHRH Agonist |
|
DiethylstilbestrolHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
|
ElacestrantHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Degrader (SERD) |
|
Ethinyl Estradiol (Oncology Use)Hormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
|
ExemestaneHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Aromatase Inhibitor |
|
FadrozoleHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Aromatase Inhibitor |
|
FlutamideHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
Antiandrogen |
|
FormestaneHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Aromatase Inhibitor |
|
FosfestrolHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
|
FulvestrantHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Degrader (SERD) |
|
GaleteroneHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
CYP17 / Androgen Synthesis Inhibitor |
|

